1 / 1

Protein Drug Characterization in Biopharmaceuticals

In line with the ICH Q6B Guidance, Creative Proteomics offers protein analysis and charac-terization services, including structure analysis, physicochemical properties, biological activi-ty, immunochemical properties, as well as purity and impurity determination to ensure thequality and consistency of your products.t<br>https://www.creative-proteomics.com/pronalyse/protein-characterization.html<br>

DoraWest
Download Presentation

Protein Drug Characterization in Biopharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Protein and Peptide Characterization in Biopharmaceuticals Molecular mass determination achieves precise molecular weights for protein/peptide drugs. Common protein drugs include antibodies (intact, deglycosylated, or reduced MW can be measured), growth factors, etc.; Common peptide drugs include insulin, cabergoline, terlipressin, etc. Molecular Weight Analysis (MALDI-TOF, LC-MS) Peptide profiling of protein/peptide drug molecules is a key element of drug quality control, which is important for theo- retical sequence confirmation, advanced structural analysis, and biological function study. Peptide profiling can confirm the theoretical sequence and modification of protein/peptide. 1) Protein sequence confirmation: visualize theoretical se- quences matching with different abundance, peptide cov- erage of conventional protein samples can reach up to 100% 2) Peptide mapping analysis: provides all information on amino acid sequences. 3) N/C-terminal amino acid sequence: provides N/C termi- nal amino acid sequence information Peptide Mapping Analysis (LC-MS/MS) 1) Glycopeptidomics analysis 2) N- or O-glycan profiling 3) Sialic acid analysis 4) Difulfide bond localization 5) Other PTMs: methylation, acetylation, phosphorylation, oxidation, etc. Modification Analysis (LC-MS/MS, MALDI-TOF) 1) Protein aggregation analysis (SEC-HPLC): protein drugs aggregate to form polymers easily. The formation of polymers may reduce the overall drug activity and en- hances side effects; thus , controlling polymer content in the final product is significant. 2) Charge state analysis (isoelectric focusing, WCX-HPLC): the occurrence of post-translational modi- fications may lead to changes in charged states and isoelectric points with protein drugs. Protein Homogeneity Analysis In line with the ICH Q6B Guidance, Creative Proteomics offers protein analysis and charac- terization services, including structure analysis, physicochemical properties, biological activi- ty, immunochemical properties, as well as purity and impurity determination to ensure the quality and consistency of your products. Contact Us © Creative Proteomics All Rights Reserved.

More Related